TAVOLIMAB

UNII: 4LU9B48U4D
Preferred Substance Name: TAVOLIMAB

1635395-25-3
HUMAN IGG1 KAPPA ANTI-HUMAN OX40 MONOCLONAL ANTIBODY MEDI0562
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD134 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL MEDI0562 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL MEDI0562 .KAPPA.-CHAIN, DIMER
MEDI0562
MEDI-0562
TAVOLIMAB [INN]
TAVOLIMAB [USAN]
TAVOLIMAB [WHO-DD]
TAVOLIXIZUMAB

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

TAVOLIMAB

Synonyms and Mappings

Resources

Note